GILD Stock: Why Things Are Looking Up Amid Coronavirus Treatment, Cancer Drugs – Investor's Business Daily

Business News

  1. GILD Stock: Why Things Are Looking Up Amid Coronavirus Treatment, Cancer Drugs  Investor’s Business Daily
  2. Gilead Sciences Mixed Results From Remdesivir Trials  FX Empire
  3. Gilead Upgraded With Covid Sales Seen Reaching $7.7 Billion  Yahoo Finance
  4. Gilead Sciences Upgraded on Potential Virus Drug Sales  TheStreet
  5. S. Korea approves emergency use of Gilead’s anti-viral drug to treat COVID-19 – The Jakarta Post  Jakarta Post
  6. View Full Coverage on Google News

Source: Business News

/by